Table 1. Patient status after TEVG implantation, as of August 2016 [all grafts are patent, but seven (28%) were complicated by stenosis].

Patient ID #	Age at surgery (years)	Graft type	Graft diameter (mm)	Patient status	Graft patency	Graft-related complications
1	2	PLA	16	Alive	Patent	None
2	1	PLA	20	Alive	Patent	None
3	8	PLA	18	Dead	Patent	Stenosis
4	22	PLA	24	Alive	Patent	None
5	13	PLA	22	Dead	Patent	None
6	4	PLA	20	Alive	Patent	Stenosis
7	14	PLA	24	Dead	Patent	None
8	17	PLA	24	Alive	Patent	None
9	22	PLA	22	Dead	Patent	None
10	4	PLA	12	Dead	Patent	Stenosis
11	2	PLA	16	Dead	Patent	None
12	2	PGA	16	Alive	Patent	Stenosis
13	2	PGA	16	Alive	Patent	Thrombosis, stenosis
14	2	PGA	18	Alive	Patent	None
15	2	PGA	12	Alive	Patent	Stenosis
16	2	PGA	16	Dead	Patent	None
17	24	PGA	18	Alive	Patent	None
18	1	PGA	16	Alive	Patent	Stenosis
19	11	PGA	18	Alive	Patent	None
20	2	PGA	14	Alive	Patent	None
21	3	PGA	16	Alive	Patent	None
22	5	PGA	18	Alive	Patent	None
23	4	PGA	18	Alive	Patent	None
24	13	PGA	16	Alive	Patent	None
25	2	PGA	18	Dead	Patent	None

TEVG, tissue engineered vascular graft; PLA, polylactic acid; PGA, polyglycolic acid.